91 related articles for article (PubMed ID: 20363224)
1. An extended antibody microarray for surface profiling metastatic melanoma.
Kaufman KL; Belov L; Huang P; Mactier S; Scolyer RA; Mann GJ; Christopherson RI
J Immunol Methods; 2010 Jun; 358(1-2):23-34. PubMed ID: 20363224
[TBL] [Abstract][Full Text] [Related]
2. A new Mr 55,000 surface protein implicated in melanoma progression: association with a metastatic phenotype.
Boukerche H; Baril P; Tabone E; Bérard F; Sanhadji K; Balme B; Wolf F; Perrot H; Thomas L
Cancer Res; 2000 Oct; 60(20):5848-56. PubMed ID: 11059782
[TBL] [Abstract][Full Text] [Related]
3. Surface antigen profiling of colorectal cancer using antibody microarrays with fluorescence multiplexing.
Zhou J; Belov L; Huang PY; Shin JS; Solomon MJ; Chapuis PH; Bokey L; Chan C; Clarke C; Clarke SJ; Christopherson RI
J Immunol Methods; 2010 Apr; 355(1-2):40-51. PubMed ID: 20156443
[TBL] [Abstract][Full Text] [Related]
4. Antibody microarray for correlating cell phenotype with surface marker.
Ko IK; Kato K; Iwata H
Biomaterials; 2005 Feb; 26(6):687-96. PubMed ID: 15282147
[TBL] [Abstract][Full Text] [Related]
5. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
[TBL] [Abstract][Full Text] [Related]
6. Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.
Ulmer A; Fischer JR; Schanz S; Sotlar K; Breuninger H; Dietz K; Fierlbeck G; Klein CA
Clin Cancer Res; 2005 Aug; 11(15):5425-32. PubMed ID: 16061857
[TBL] [Abstract][Full Text] [Related]
7. Screening microarrays of novel monoclonal antibodies for binding to T-, B- and myeloid leukaemia cells.
Belov L; Huang P; Chrisp JS; Mulligan SP; Christopherson RI
J Immunol Methods; 2005 Oct; 305(1):10-9. PubMed ID: 16125720
[TBL] [Abstract][Full Text] [Related]
8. Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.
Kaufman KL; Mactier S; Armstrong NJ; Mallawaaratchy D; Byrne SN; Haydu LE; Jakrot V; Thompson JF; Mann GJ; Scolyer RA; Christopherson RI
Clin Exp Metastasis; 2014 Apr; 31(4):407-21. PubMed ID: 24435119
[TBL] [Abstract][Full Text] [Related]
9. Glycoconjugate profiling of primary melanoma and its sentinel node and distant metastases: implications for diagnosis and pathophysiology of metastases.
Thies A; Berlin A; Brunner G; Schulze HJ; Moll I; Pfüller U; Wagener C; Schachner M; Altevogt P; Schumacher U
Cancer Lett; 2007 Apr; 248(1):68-80. PubMed ID: 16822608
[TBL] [Abstract][Full Text] [Related]
10. The semaphorin 7A receptor Plexin C1 is lost during melanoma metastasis.
Lazova R; Gould Rothberg BE; Rimm D; Scott G
Am J Dermatopathol; 2009 Apr; 31(2):177-81. PubMed ID: 19318806
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotyping of leukemias using a cluster of differentiation antibody microarray.
Belov L; de la Vega O; dos Remedios CG; Mulligan SP; Christopherson RI
Cancer Res; 2001 Jun; 61(11):4483-9. PubMed ID: 11389079
[TBL] [Abstract][Full Text] [Related]
12. Prediction of non-sentinel node status and outcome in sentinel node-positive melanoma patients.
Roka F; Mastan P; Binder M; Okamoto I; Mittlboeck M; Horvat R; Pehamberger H; Diem E
Eur J Surg Oncol; 2008 Jan; 34(1):82-8. PubMed ID: 17360144
[TBL] [Abstract][Full Text] [Related]
13. Effect of melanoma on immune function in the regional lymph node basin.
Negin B; Panka D; Wang W; Siddiqui M; Tawa N; Mullen J; Tahan S; Mandato L; Polivy A; Mier J; Atkins M
Clin Cancer Res; 2008 Feb; 14(3):654-9. PubMed ID: 18245524
[TBL] [Abstract][Full Text] [Related]
14. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.
van Duinen SG; Ruiter DJ; Broecker EB; van der Velde EA; Sorg C; Welvaart K; Ferrone S
Cancer Res; 1988 Feb; 48(4):1019-25. PubMed ID: 3338074
[TBL] [Abstract][Full Text] [Related]
15. Immunomagnetic detection and clinical significance of micrometastatic tumor cells in malignant melanoma patients.
Faye RS; Aamdal S; Høifødt HK; Jacobsen E; Holstad L; Skovlund E; Fodstad Ø
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4134-9. PubMed ID: 15217950
[TBL] [Abstract][Full Text] [Related]
16. A micromorphometry-based concept for routine classification of sentinel lymph node metastases and its clinical relevance for patients with melanoma.
Starz H; Balda BR; Krämer KU; Büchels H; Wang H
Cancer; 2001 Jun; 91(11):2110-21. PubMed ID: 11391592
[TBL] [Abstract][Full Text] [Related]
17. [Important prognostic significance of a sentinel-node biopsy in patients with malignant melanoma].
Keijzer R; Bril H; van der Loo EM; de Graaf PW
Ned Tijdschr Geneeskd; 2004 May; 148(18):884-8. PubMed ID: 15152391
[TBL] [Abstract][Full Text] [Related]
18. Loss of EphB6 expression in metastatic melanoma.
Hafner C; Bataille F; Meyer S; Becker B; Roesch A; Landthaler M; Vogt T
Int J Oncol; 2003 Dec; 23(6):1553-9. PubMed ID: 14612926
[TBL] [Abstract][Full Text] [Related]
19. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
20. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
